Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Feasibility/Efficacy Study of HIFU in Otherwise Untreatable Pelvic Rectal Cancer

NCT01097239 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01097239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01097239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Feasibility/Efficacy Study of HIFU in Otherwise Untreatable Pelvic Rectal Cancer
Lead sponsor
Imperial College London
Phase
Phase 1/2
Overall status
Withdrawn
Start date
November 30, 2009
Completion date
September 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, ovarian cancer, rectal cancer, vaginal cancer